BioNTech SE
Compositions and Methods for Diagnosis and Treatment of Cancer
Last updated:
Abstract:
The present invention relates to the diagnosis and treatment of diseases expressing Fibronectin Extra Domain B (EDB) such as diseases characterized by tissue remodeling and/or angiogenesis, in particular cancerous diseases, such as head and neck, brain, colorectal, lung, prostate and breast cancer. More particularly, the invention concerns peptides targeting Fibronectin Extra Domain B.
Status:
Application
Type:
Utility
Filling date:
6 Jun 2019
Issue date:
12 Aug 2021